Cengild Medical Berhad (KLSE:CENGILD)
Malaysia · Delayed Price · Currency is MYR 0.1950
0.00 (0.00%)
At close: Sep 2, 2026
Cengild Medical Berhad Financials Overview
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 73.21 | 73.21 | 80 | 66.82 | 70.28 | 64.44 |
Revenue Growth | -8.49% | -8.49% | 19.72% | -4.92% | 9.06% | 1.53% |
Gross Profit Gross Profit Growth | 34.59 | 34.59 | 36.87 | 31.07 | 30.73 | 26.05 |
Operating Income Operating Income Growth | 13.53 | 13.53 | 14.33 | 13.21 | 14.46 | 11.57 |
Net Income Net Income Growth | 11.44 | 11.44 | 11.06 | 11.08 | 13.29 | 9.39 |
Earnings Per Share EPS Growth | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
EPS Growth | 3.20% | 3.20% | -0.19% | -17.39% | 10.46% | -12.59% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 47.64 | 47.64 | 85.24 | 90.42 | 99.03 | 87.07 |
Total Debt Total Debt Growth | 85.94 | 85.94 | 47.55 | 8.14 | 14.93 | 16.21 |
Net Cash (Debt) Net Cash Growth | -38.3 | -38.3 | 37.69 | 82.27 | 84.1 | 70.87 |
Net Cash Growth | - | - | -54.18% | -2.17% | 18.67% | - |
Net Cash Per Share Net Cash Per Share Growth | -0.05 | -0.05 | 0.05 | 0.10 | 0.10 | 0.11 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 13.1 | 13.1 | 16.08 | 12.94 | 13.91 | 15.33 |
Capital Expenditures CapEx Growth | -81.35 | -81.35 | -37.26 | -15.73 | -2.13 | -0.43 |
Free Cash Flow Free Cash Flow Growth | -68.25 | -68.25 | -21.18 | -2.8 | 11.78 | 14.9 |
Free Cash Flow Growth | - | - | - | - | -20.92% | 18.27% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 47.26% | 47.26% | 46.10% | 46.50% | 43.72% | 40.42% |
Operating Margin | 18.48% | 18.48% | 17.91% | 19.77% | 20.58% | 17.95% |
Pretax Margin | 19.17% | 19.17% | 22.51% | 25.04% | 24.72% | 18.80% |
Profit Margin | 15.63% | 15.63% | 13.82% | 16.58% | 18.91% | 14.57% |
FCF Margin | -93.22% | -93.22% | -26.48% | -4.19% | 16.77% | 23.12% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.004 | 0.004 | 0.010 | 0.007 | 0.007 | 0.004 |
Dividend Per Share Growth | -62.89% | -62.89% | 31.08% | 0% | 100.00% | - |
Dividend Yield | 1.80% | 1.85% | 4.35% | 2.51% | 2.04% | 1.03% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 14.23 | 14.20 | 17.33 | 23.68 | 24.76 | 34.88 |
Forward PE | - | 23.00 | 23.00 | 23.00 | 23.00 | 24.24 |
P/FCF Ratio | - | - | - | - | 27.92 | 21.98 |
PS Ratio | 2.22 | 2.22 | 2.40 | 3.93 | 4.68 | 5.08 |